Clinical Trial

BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors

Name: BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors — clinical trial record (NCT07196111)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Withdrawn Early Phase 1

View on ClinicalTrials.gov →

Why the trial stopped

Due to corporate strategic adjustment.

Summary

This study is a single-arm, multicenter clinical trial of dose escalation and dose expansion.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-09-19.

Status change: Not Yet Recruiting → Withdrawn 2026-05-26

Trial Details

NCT Number	NCT07196111
Lead Sponsor	Guangzhou Bio-gene Technology Co., Ltd
Conditions	B Acute Lymphoblastic Leukemia/Lymphoma
Start Date	2025-10-10
Primary Completion	2028-10-09 (estimated)
Study Completion	2028-12-09 (estimated)
Updated on ClinicalTrials.gov	2026-05-28